Home » Clinical Trials » DefINe: A trial to test the use of deferiprone in people with neuroferritinopathy
DefINe: A trial to test the use of deferiprone in people with neuroferritinopathy

Research area:

Rare disease

Disease:

Neuroferritinopathy

Intervention:

Therapeutics – small molecules

Phase:

Phase II

Funding awarded to

University of Cambridge

Public registration details (where available)

ISRCTN15571700

Related news

Dementia Consortium funds Manchester based team targeting immune system in search for new dementia treatments

Read more: Dementia Consortium funds Manchester based team targeting immune system in search for new dementia treatments

MRC Technology invests £7 million to expand its diagnostics research capability in Scotland

Read more: MRC Technology invests £7 million to expand its diagnostics research capability in Scotland

UK Drug Discovery Consortium symposium

Read more: UK Drug Discovery Consortium symposium